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Intranasal oxytocin produces anorectic effects on snack intake in men when tested in the absence of 
deprivation-induced hunger, but its effects on food intake in women without eating disorders have not 
been reported. Oxytocin may reduce food intake by reducing stress eating, since it inhibits ACTH 
release. The present study adopted a double-blind, repeated measures and fully concealed crossover 
protocol in which 38 women self-administered 24 IU of oxytocin or placebo intranasally, ate lunch, 
and underwent two consecutive stress tests. Snack intake was assessed 15-20 minutes after lunch, via 
a sham taste test. Salivary cortisol was measured throughout the test period every 15 minutes. 
Oxytocin significantly reduced sweet fatty snack intake independently of any effect on salivary 
cortisol, which declined over time at a similar rate after either drug or placebo. Ratings of sweet taste 
were slightly reduced by oxytocin, but only in self-reported stress eaters. These results differ from 
previous studies with men that found an effect of oxytocin on postprandial cortisol levels. However, 
previous research assayed the less active form of plasma cortisol and did not control for protein 
intake, which can drive elevated cortisol. The finding that oxytocin reduces snack intake in females 
after acute stress has important implications for appetite regulation and its treatment in obese people 





























































Oxytocin (OT) is a hypothalamic neuropeptide hormone, released into the circulation via the posterior 
pituitary gland that also has central actions known to affect social behaviours (Jones, Barrera, 
Brothers, Ring, & Wahlestedt, 2017). In experimental animals and humans, OT inhibits palatable food 
intake and alters macronutrient metabolism (Leng & Sabatier, 2017; Leslie, Silva, Paloyelis, Blevins, 
& Treasure, 2018). OT also regulates the hypothalamo–pituitary–adrenal axis (HPA) and is released 
both centrally and peripherally in response to both psychological (Carter & Altemus, 1997; Onaka, 
Takayanagi, & Yoshida, 2012) and physical stress (Cardoso, Ellenbogen, Orlando, Bacon, & Joober, 
2013). However, relatively little is known about the role of OT in mediating either the hypophagic or 
hyperphagic effects of stress in human beings; thus, the present study aimed to examine the impact of 
intranasal OT on snack intake with an emphasis on sweet snack intake in women after a stressful task.    
In rats, a dose-dependent reduction in sucrose intake following OT administration has been shown to 
be dependent on activation of oxytocin receptors (OTR) in the ventral tegmental area (VTA Mullis, 
Kay, & Williams, 2013). Activity of the VTA is known to influence palatable food consumption, 
reward, and various motivated behaviours (Lutter and Nestler, 2009) and it has been suggested that 
oxytocin may, therefore, alter the motivation to eat in the absence of hunger. OT knockout (KO) mice 
overconsume sweet-tasting sucrose and noncaloric saccharin but not lipid emulsions (Amico, 
Vollmer, Cai, Miedlar, & Rinaman, 2005). The increased consumption of sucrose solution in OT KO 
mice is not altered by daily shaker platform stress (Billings, Spero, Vollmer, & Amico, 2006), 
suggesting that sucrose hyperphagia in OT KO mice is independent of stress and activation of the 
HPA axis. Furthermore, Sclafani et al. (2007) demonstrated, using isotonic carbohydrate solutions 
that varied in sweetness, that hyperphagia in OT KO mice could be extended to carbohydrate intake in 
general, but did not occur for a palatable, fat-rich emulsion (Intralipid): therefore OT brain pathways 
may contribute to carbohydrate-specific satiation, at least in rodents.
In humans, administration of 24 IU of intranasal oxytocin markedly decreased palatable snack intake 




























































4Higgs, and Terry, 2018). The reductions in total snack intake were primarily driven by a 37% decline 
in sweet snack consumption, specifically chocolate cookie consumption, but a significant attenuation 
of salty cracker intake was also seen. In the same experiment, the intake of bland-tasting oatcakes was 
not affected by OT. A similar effect on sweet snack intake was found by Ott et al. (2013): twenty 
young male participants ate a buffet breakfast, then 1 hour 40 minutes later an OT-induced reduction 
of chocolate cookie intake (by 25%) was found. These studies suggest that OT has anorectic 
properties and may form part of the homeostatic regulatory system of the hypothalamus, interacting 
with hormonal signals such as leptin and cholecystokinin (CCK) to inhibit food intake (Sabatier, 
Leng, & Menzies, 2014). However, factors other than sufficient calorie intake appear to stimulate 
neuronal OT release coinciding with termination of feeding. These include meal onset (Sabatier et al., 
2014), changes in blood osmolality as a result of increased salt intake (Stricker & Verbalis, 1986), 
stomach distension (Calatayud, Quintana, Esplugues, & Barrachina, 1999) and toxin ingestion 
(Olszewski, Waas, Brooks, Herisson, & Levine, 2013). Together, this evidence suggests that OT may 
regulate palatable carbohydrate intake in a non-homeostatic manner, i.e. not dependent on normal 
satiation processes.
OT also interacts with other hormonal systems. The sex steroids, in particular the oestrogens, are 
important regulators of the OT system, resulting in a sex disparity in OT synthesis and receptor 
expression. Oestrogen receptors are expressed in hypothalamic OT neurons, and activation of these 
receptors enhances the anxiolytic effects of OT, suggesting a regulatory role for oestrogen in OT 
release. In addition, oestrogens influence the transcription of both OT and its receptors (McCarthy, 
McDonald, Brooks, & Goldman, 1996; Olszewski et al., 2013; Young, Wang, Donaldson, & Rissman, 
1998). To a lesser extent, testosterone influences OT receptor expression, and its effects vary 
according to brain region (Insel, Young, Witt, & Crews, 1993). Relatedly, sex hormones exert sex-
dependent stress effects that can lead to higher stress levels in women than men. Premenopausal 
women, for example, are vulnerable to monthly variations in oestrogen and progesterone that regulate 
central levels of serotonin and the progesterone metabolite, allopregnanolone, two endogenous 




























































5between OT and oestrogen systems which may at least partially explain the sex-dependent effects of 
OT on certain behaviours (Carter, 2007; Choleris et al., 2003; Rilling et al., 2014).
Intracerebral OT given to rats that were exposed to emotional and physical stressors inhibited basal 
HPA axis activity but potentiated adrenocorticotropic hormone (ACTH) release under stress 
conditions, indicating a differential involvement of central OT on HPA axis functioning (Neumann, 
Krömer, Toschi, & Ebner, 2000). This effect was reversible by OT receptor antagonism (Neumann, 
Torner, & Wigger, 1999; Neumann, Wigger, Torner, Holsboer, & Landgraf, 2000) clearly indicating 
an OT receptor-mediated effect. In a further experiment, both the tonic reductions in HPA axis 
activity induced by brain OT as well as on the stress-induced release of ACTH by intracerebral OT 
were shown to be sex independent (2000). In rat dams and women, lactation-related rises in OT 
reliably reduce ACTH and corticosterone/cortisol (Amico, Johnston, & Vagnucci, 1994; Chiodera et 
al., 1991). Oxytocin and cortisol levels are bi-directionally interactive (Tops, Van Peer, Korf, Wijers, 
& Tucker, 2007) and cortisol levels appear so tightly linked to oxytocin that cortisol measurement has 
been used as an experimental proxy for oxytocin (Meinlschmidt & Heim, 2007). In previous studies 
showing OT’s attenuation of palatable food intake, a concomitant decrease in cortisol was found after 
OT administration but not after placebo, perhaps indicating that a cortisol-mediated effect underlies 
OT’s influence on  palatable snack intake (Ott et al., 2013; Thienel et al., 2016).
In women with high cortisol reactivity to an acute stressor, greater stress-induced eating is observed 
(Epel, Lapidus, McEwen, & Brownell, 2001), and although about equal numbers of the population 
overeat and undereat, as do neither (Wardle & Gibson, 2016), there is a gender disparity, with women 
typically engaging in stress eating more frequently than men (Gibson, 2012). Eating energy-dense 
foods can relieve the negative consequences of stress and suppress the HPA axis (Buwalda, Blom, 
Koolhaas, & van Dijk, 2001; Dallman et al., 2003; Foster et al., 2008; Pecoraro, Reyes, Gomez, 
Bhargava, & Dallman, 2004). Eating in response to stress typically involves choosing highly palatable 
and energy-dense foods (Oliver, Wardle, & Gibson, 2000; Pliner & Mann, 2004) but the severity of 
the stressor may influence these patterns (Charmandari, Tsigos, & Chrousos, 2005). Acute stressors 




























































6leave eating unchanged (Wardle & Gibson, 2016). Chronic stress may have the opposite effect: for 
instance, chronically-stressed women who comfort eat have been shown to have a blunted cortisol 
response to an acute stressor (Tomiyama, Dallman, & Epel, 2011). A suppressed cortisol response 
may also arise from the accumulation of visceral fat (Tomiyama et al., 2011), but using acute stressors 
such as public speaking and mathematical tasks, laboratory studies have produced robust stress-eating 
responses irrespective of BMI (Epel et al., 2001).  
Given the prevalence of stress eating in women and the central elevation of OT by oestradiol, we 
would expect a sex difference with respect to the impact of OT administration on stress eating, with 
the inhibition of snack eating by OT likely to be enhanced in females. Here we investigate, for the 
first time, the effect of OT on stress-related snack intake that is not initiated by deprivation-induced 
hunger in women.  To minimise the possibility that the effects of OT may be attributed to the 
modulation of such hunger-driven eating, participants were provided with lunch 20 minutes before a 
post-stress covert snack-eating test.  Salivary cortisol was measured at frequent intervals for the first 
time in this OT and stress-eating experimental paradigm; furthermore, to avoid cortisol increases 
provoked by protein consumption (Gibson et al., 1999), the protein content of the preloaded food was 
kept below 10 g.  
2. MATERIALS AND METHODS
2.1 Design
 A double-blind, placebo-controlled, randomised, and counterbalanced crossover protocol was 
implemented using a within-subjects design comprising drug or placebo tests scheduled about a week 
apart. The aims of the experiment were disguised to minimise undesirable impression management 
and participants were informed that the study investigated the effect of OT on stress and sensory 






























































7Thirty-eight healthy women aged between 19 and 51 years, M (SD) = 26.6 (8.6) years were recruited 
both by word-of-mouth and in exchange for university course credits. Their body mass indices ranged 
from 18.4 to 35.0 kg/m2, M (SD) = 24.8 (4.2) kg/m2, indicating a range from low to obese. Although 
participants were not selected on the basis of their stress eating, we used a bespoke questionnaire that 
asked about a range of stress responses that included effects on eating, in order to disguise the 
experimental aims. The questionnaire asked participants to indicate how they react to a number of 
stress scenarios by rating their top three responses from the following options: “sleep”, “disturbed 
sleep”, “exercise”, “chat with someone”, “work/study”, “eat”, “reduced eating”, “smoke/vape”, 
“read/watch TV or film”, “cry”, “drink alcohol”, “let your hair down”, “drugs of abuse”, and “none of 
the options”.  Although all of the women demonstrated they were premenopausal by providing the 
date of their most recent menstrual cycle, at least three women (aged 46, 48 and 51 years) may have 
been perimenopausal due to their age.  Participants with self-declared food allergies, diabetes, 
pregnant, breastfeeding, on prescription medicines or a vegan diet, were excluded. Altered 
endogenous OT function is associated with high emotional arousal or stress (e.g. bereavement, 
financial windfall) so participants reporting such events were also excluded (Engelmann, Ebner, 
Landgraf, Holsboer, & Wotjak, 1999; Kovacs, 1986). Due to possible changes in taste sensitivity and 
suppressed eating (Audrain-McGovern & Benowitz, 2011; Gromysz-Kalkowska, Wojcik, 
Szubartowska, & Unkiewicz-Winiarczyk, 2002), regular smokers were also excluded. Participants 
were asked not to consume alcohol or non-steroidal anti-inflammatory drugs for 24 hours beforehand 
and to abstain from consuming food and sugary drinks for two hours before the experiment.
2.3 Materials
OT and vehicle were supplied by Victoria Pharmacy, Switzerland. Salter’s electronic food scales were 
used to weigh food and Koogeek’s biometric impedance scales were used to weigh participants and 
estimate fat ratio. Blood glucose levels were obtained using Accu-Chek’s ‘Aviv’ hand-held monitor, 
the Omron handheld M2 model measured blood pressure, and Biopac’s SC-Flex Pro was used with a 
fingertip sensor to measure heart rate. Saliva was collected in ‘Salivettes’ (Sarstedt UK, Leicester, 





























































Sham sensory tasks used the following: Elite Healthcare’s ‘Two Point Discriminator Touch-Test’; 
synthetic almond- and soap-scented smelling bottles (Bilendy Ltd, UK); and a stopwatch. Bespoke 
materials for the sham visual tasks were A4-sized laminated colour prints of famous paintings and 
A6-sized laminated black-and-white pictures of castles for the “spot-the-difference” test. Music and 
Neuroimaging Laboratory’s pitch discrimination test was taken online (Schlaug, 2017). 
Self-report measures: Romantic involvement was estimated using Rubin’s (1970) Romantic Love 
Scale. Self-monitoring behaviour was assessed using Synder’s scale (1974) and anxiety was estimated 
with the trait scale of the State-Trait Anxiety inventory (STAI; Spielberger, Gorsuch, & Lushene, 
1970). The Dutch Eating Behaviour Questionnaire (DEBQ Van Strien, Frijters, Bergers, & Defares, 
1986) assesses levels of restrained (10 items), emotional (13 items), and external (10 items; one 
reversed) eating, with each scale having a range of mean scores from 1 to 5; a higher score reflects 
higher levels of the eating dimension.
Mood and appetite parameters were measured using a bespoke visual analogue scale (VAS) 
examining levels of happiness, excitement, fullness, thirst, anxiousness, and alertness with 100 mm 
lines anchored at “not at all” and “as much as I can imagine”. For the taste test, VAS lines fixed by 
“not at all” and “as much as I can imagine” were presented to measure oatcake palatability, cracker 
saltiness, and chocolate cookie sweetness.  
For the low-protein lunch, each participant was provided with a pre-packaged supermarket lunch 
(Waitrose ‘Pesto and Spinach Salad’, 376 kcal, 190 g).  In the snack test, the three foods were 
chocolate cookies (Waitrose ‘Triple Chunk Chocolate Chip’, 127 kcal, 25 g per unit, 450 g per bowl), 
TUC Classic Crackers (17 kcal, 5.4 g per unit, 230 g per bowl), and Sainsbury’s Oatcakes (47 kcal, 
10.4 g per unit, 300 g per bowl). As per previous experiments, each snack-food type was matched for 
calorie content and macronutrients (see Burmester, Higgs, & Terry, 2018, for full details) and 
presented in a separate bowl filled to the top, in order that substantial amounts could be eaten without 





























































The timeline of events in a test session is shown in Table 1. After providing informed consent and 
confirming compliance with the inclusion and exclusion criteria, participants provided the first of two 
baseline saliva samples by drooling into the collection tube; at least 1 ml was collected with each 
sample. Participants next completed the first of three mood VAS scales. Baseline blood pressure was 
taken as a biomarker of stress, and baseline blood glucose was then measured as OT affects 
postprandial glucose metabolism. Participant height, age, time since last meal, and content of last 
meal were recorded, and the second baseline cortisol sample was collected.  
Next, the participant self-administered either 24 IU of OT or placebo, depending on session, under the 
supervision of the researcher, with six puffs alternated by nostril every 30 seconds; both the 
participant and the researcher were blind to the drug condition. Before participants were asked to eat 
the lunch provided, a measure of romantic love status (Rubin, 1970) was obtained in each session, 
because romantic attachment can influence OT’s effects. Because thirst can sometimes be experienced 
as hunger (Balleine, 1994), participants were offered water and a maximum of 100 ml was provided 
with their lunch; participants were also required to rinse out their mouths with a small sip of water 
after food to reduce salivary sample contamination. 
To support the purpose of the study as it had been described to the participants, two sham sensory 
tasks were presented: a two-point discrimination touch test was conducted on the right index finger to 
identify the smallest interval, in millimetres, that could be sensed, and an olfactory test with smelling 
bottles containing synthetic soap or almond scents, depending on session, was then presented. Saliva 
was again drooled into the Salivettes and the participant’s left hand was rested on the table top and a 
heart rate sensor placed on the middle finger. While keeping the hand still a 10-minute baseline 
recording was made while the participant watched a neutral film, at the end of which they were 
allowed to move their arm briefly and re-position it, if uncomfortable.  
Stress was then induced by the participant being instructed to sing a song for a minute; heart rate 





























































selection or style, and the researchers stopped all activity to create tension and watched the participant 
whose 60 seconds of singing was timed by stop-watch. At the end of the singing, the heart rate 
recording was paused, and the participant was instructed on the serial sevens task (Smith, 1967). 
Heart rate recording was resumed and a random starting number between 700 and 800 was given and 
the participant began 60 seconds of subtracting seven from the running total. Immediately following 
the second stress test, a saliva sample was taken, and blood pressure was measured.  
Next, a taste test was conducted with the three snack foods. Small pieces of each snack, weighing 
about a gram, were provided for the participant to taste and rate on a VAS. Another mood/hunger 
VAS was then completed, and the sham pitch test was completed online. After the pitch test, another 
saliva sample was taken, followed by the first sham visual task, which involved presenting one of two 
near-identical spot-the-difference pictures for 30 seconds. Then the critical snack test occurred: at 45-
minutes post drug/placebo administration, the participant was instructed to enjoy a 10 minute 
‘cognitive break’, let her mind ‘relax’, and select a preferred picture from a choice of five A4-sized 
prints of famous paintings. The experimenters announced that they would leave the room during the 
participant’s ‘cognitive break’, and it was mentioned that the snack food would be thrown away after 
the experiment due to health and safety regulations, therefore they were free to help themselves to as 
much of the snack food as they wished. The snack test period lasted 10 mins, after which the second 
spot-the-difference picture was presented for 30 seconds, and the participant was asked to identify the 
difference between the two pictures.  
After the break, the participant provided another saliva sample and completed a mood/hunger VAS.  
Next, the STAI was completed as a subjective measure of participant stress, then blood pressure and 
blood glucose were measured. One last saliva sample was provided. Finally, before participants left, 
they were asked whether they thought they had been given OT or placebo. At the end of the second 
visit, participant body mass was measured. Lunch and snack test foods were weighed before and after 
testing. Each session lasted about 95 mins; after the completion of the experiment, participants were 






























































Table 1: Timeline of Experimental Session
Saliva assays for cortisol: Samples were centrifuged at 1000 × g for 2 min, and supernatant was stored 
at −20C for 1 to 6 days and then -80C until assay.  Saliva cortisol levels were measured all in the 
same day in duplicate by Surrey Assays Ltd by radioimmunoassay adapted from Riad-Fahmy et al. 
(1979). Limit of detection was 0.44 +/- 0.15 nmol/L and quality controls were low = 3.2 +/- 0.4 
nmol/L CV = 11.6%; medium = 17.7 +/- 1.7 nmol/L CV = 9.6%, and high = 48.2 +/- 3.2 nmol/L CV 
= 6.7%.
2.5 Data analysis
Data were analysed using Statistical Package for the Social Sciences software (SPSS) version 25.  
Stress eating status was determined from the bespoke questionnaire by a participant indicating that 
eating was a stress response to one or more of the six situations presented. To grade the stress eating, 
a count of the number of situations that triggered stress eating was made for participants who reported 
stress eating to give a score from 1 to 6.  Differences in chocolate cookie consumption, salty cracker 
consumption, oatcake consumption and snack food sensory taste tests for self-rated stress eaters and 





































































































































































































































































conditions.  Taste sensitivity measures were also analysed using a repeated-measures analysis of 
variance (RMANOVA) for OT and placebo conditions.  Baseline-adjusted scores were calculated for 
self-reported mood and appetite VAS by subtracting scores from the first VAS before administration 
of OT or placebo from scores on the second VAS and scores on the third VAS and analysed via t tests 
and a 2 (Drug: OT or placebo) x 2 (Time: post stress or post stress + 30’) RMANOVA was conducted 
for each of the VAS items using baseline-adjusted change scores.  The means of the two baseline 
cortisol samples (sample 1 and sample 2) were subtracted from each of the remaining samples within 
the same session (samples 3 to samples 7) to create baseline-adjusted data.    Both area under the 
curve with respect to increase (AUCi)  and a RMANOVA were used to compare baseline-adjusted 
cortisol scores for salivary cortisol levels of samples 3 to 7 taken at 15-, 30-, 45-, 60-, and 75-minutes 
post administration between drug conditions (Figure 4).
3. RESULTS
3.1 Participant Characteristics
For the dietary restraint component of the DEBQ, participants scored higher than the mean of 
normative scores [M (SD) = 2.75(0.79)] from the British validation of the DEBQ using healthy 
women (Wardle, 1987); M (SD) = 3.19 (1.1). Participants scored slightly above a normative mean [M 
(SD) = 3.19 (1.1)] on the DEBQ external eating scale, M (SD) = 3.33 (0.59), but at the low end of 
normative data [M (SD) = 2.65 (0.72)] for emotional eating, M (SD) = 1.93 (0.76).  Scores on the self-
monitoring scale were below average, M (SD) = 8.89 (2.65) and scores on the STAI (range from 0-80) 
were above normative averages [trait: M = 34.79, SD = 9.22 and state: M = 37.89, SD = 9.90] for both 
trait, M (SD) = 45.50 (4.61) and state, M (SD) = 44.91 (3.04) components. Scores on the romantic 
love scale were low-average M (SD) = 76.65 (14.86) and were no different between placebo and 
oxytocin conditions: t(37) = 0.14, p = .89.
Self-Rated Stress Eating Status: The DEBQ emotional eating scores for self-reported stress eaters (M 





























































F(1,26) = 0.006, p = .94]. 
3.2 Snack food intake
There was no main effect of stress eating status on consumption of snack foods: F(1,36) = 0.14, p = 
.71. There was, however, a main effect of OT [F(1,36) = 12.38, p < .001, partial η2 = .26; see Figure 
1], whereby significantly less snack food in total was eaten in the OT condition, p = .001, and this was 
not qualified by an interaction with stress eating status: F(1,36) = 2.57, p = .12. The assumption of 
sphericity was violated for snack type [χ2(2) = 28.14, p < .001] and the interaction between snack type 
and drug [χ2(2) = 19.22, p < .001], so Greenhouse-Geisser adjustments were used: ε = 0.64 for snack 
type, ε = 0.71 for interaction. A main effect of snack type was found: F(1.29,46.38) = 24.75, p < .001, 
partial η2 = .41. Post-hoc Bonferroni comparisons showed that significantly more of sweet (chocolate 
cookies) than salty (crackers) snacks were consumed (p < .001), and significantly more of sweet than 
bland (oatcakes) snacks were eaten (p < .001). There was no significant difference between salty and 
bland snack consumption (p = .28); thus, overall participants ate more chocolate cookies than other 
snack types. There was no interaction between snack type and participants’ self-rated stress eating 
status: F(1.29,46.38) = 0.60, p = .48. There was, however, a significant interaction between drug 
condition and snack type [F(1.41,50.61) = 19.71, p = < .001], such that participants ate considerably 
less chocolate snack in the OT condition (Figure 1). The interaction between drug condition and snack 




















































































Figure 1: Effects of 24 IU oxytocin (OT) vs. placebo on the intake (mean g ± SEM; n = 38) of three 
different snacks collapsed across stress eaters (n = 15) and non-stress eaters (n = 23). Choc Bisc = 
chocolate chip cookies.
The drug by snack type interaction was further examined by post-hoc t tests. There were no 
differences in snack consumption between stress eaters and non-stress eaters, so participants were 
analysed as a whole. OT significantly reduced the intake of chocolate cookies [t(37) = 5.10 p < .001] 
but not salty crackers [t(37) = .262 p = .80] or oatcakes [t(37) = 1.18 p = .25]. As expected, there was 
no significant difference between conditions on the consumption of lunch (a study requirement), t(37) 
= .74 p = .47.  
3.3 Snack Food Sensory Taste Tests
OT tended to reduce the reported sweetness of the chocolate cookies for stress eaters but tended to 
increase rated sweetness for non-stress eaters [Figure 2: drug x stress eating interaction, F(1,36) = 





























































(Fs < 1): overall mean sweetness ratings for chocolate cookies were 77.50 mm (SD = 12.76) in the 
placebo condition and 77.76 mm (SD = 13.50) after OT, i.e. did not differ, t(37) = 0.11 p = .91 .  
The mean saltiness ratings for crackers were similar in both the placebo (55.79 mm, SD = 19.52 mm) 
and oxytocin conditions (56.26 mm, SD = 17.41 mm), t(37) = 0.17 p = .87.  However, self-reported 
stress eaters rated crackers as significantly saltier than did non-stress eaters, irrespective of drug 
[Figure 3: stress eater status main effect, F(1,36) = 5.16, p = .029, partial η2 = .13].  The drug effect 
and interaction effect were not significant (Fs  < 1).




































Self-Reported Stress Eating Status
 
Figure 2: Interaction of drug (oxytocin vs placebo) and stress eating status (stress eater [n=15] vs non-





























































































Self-Reported Stress Eating Status
Figure 3: Interaction of drug (oxytocin vs placebo) and stress eating status (stress eater [n=15] vs non-
stress eater [n=23]) on rated saltiness of crackers.
Oatcakes were rated similarly for palatability in the placebo condition (M = 34.92 mm, SD = 22.46 
mm) as in the oxytocin condition (M = 37.63 mm, SD = 26.53 mm) t(37) = 0.62 p = .54, and 
palatability ratings did not differ between stress eating groups (Fs < 1.1).  
3.4 Self-reported mood and appetite VAS
Overall, there were no significant differences between drug conditions for changes in alertness, 
anxiety, happiness, excitement, fullness or thirst.  However, over the course of the placebo session 
there was a significant decline in ratings of happiness [t(37) = 2.17 p =  .037], excitement [t(37) = 
2.85 p = 0.07], and alertness [t(37) = 2.62 p = .013], whereas in the OT session, participant ratings of 





























































VAS item Time point Placebo OT
M SD M SD
Alert Baseline 51.50 23.13 53.39 23.61
Post-stress 49.58 22.45 47.74 24.38
Post-stress+30’ 42.58 23.14 48.87 22.81
Anxious Baseline 20.74 20.38 22.21 22.87
Post-stress 19.34 18.70 17.21 16.97
Post-stress+30’ 18.68 18.94 17.87 15.68
Excited Baseline 36.32 19.76 38.21 22.49
Post-stress 38.71 24.38 37.55 22.08
Post-stress+30’ 31.76 19.77 35.45 23.36
Full Baseline 23.45 19.78 31.92 24.59
Post-stress 60.39 22.59 60.71 20.44
Post-stress+30’ 64.53 22.45 64.84 23.30
Happy Baseline 58.68 18.11 56.29 21.12
Post-stress 62.89 16.06 57.29 19.02
Post-stress+30’ 58.18 18.86 58.24 19.83





























































Post-stress 68.47 20.64 59.29 23.23
Post-stress+30’ 68.18 22.76 66.58 24.88
Table 2: Mean (SD) 100-mm VAS mood and appetite ratings for oxytocin (OT) and placebo 
conditions over baseline and post-stress time points (n = 38)
There was no main effect of drug condition [F(1,37) 0.23, p = .89] or sample time [F(1,37) 1.84, p = 
.12] for the “happiness” item but there was a significant interaction between drug and sample time 
[F(1,37) 5.13, p = .029, partial η2 = .12] such that self-rated happiness declined from a slight rise 
immediately post-stress to the end of the session in the placebo condition but it did not drop in the 
oxytocin condition. There were no further main effects or interactions for the remaining VAS items, 
except that self-rated “excitement” decreased significantly by the last measure in both drug conditions 
[F(1,37) = 9.07, p = .005, partial η2 = .20] and ratings of fullness increased significantly through both 
sessions [F(1,37) = 6.80, p = .013, partial η2 = .15].
3.5 Cortisol
Oxytocin did not significantly change cortisol levels [F(1,37) = .85, p = .36]. Mauchly’s test indicated 
that the assumption of sphericity had been violated for the sample time factor [χ2(9) = 72.00, p < .001] 
and the interaction between sample and drug [χ2(9) = 36.29, p < .001], so degrees of freedom were 
estimated using the Greenhouse-Geisser estimates of sphericity (ε = 0.50 for sample, ε = 0.65 for 
interaction).  As expected, there was a main effect of sample time with salivary cortisol quantities 
dropping over time [F(2.0, 74.1) =  7.76, p = .001, partial η2 = .10] but there was no interaction with 
drug [F(2.6, 96.0) =  0.82, p = .47].
No significant differences between drug conditions were seen in a repeated-measures ANOVA using 
the AUCi of baseline-adjusted cortisol, F(1,37) 0.74, p = .40.  Paired t tests on peak cortisol were not 
significantly different between conditions using baseline-adjusted data, t(37) = .74, p = .47, and t tests 





























































Finally, there was no significant correlation between AUCi measures and chocolate cookie snack 























Figure 4: Baseline-adjusted salivary cortisol concentration (nmol/L; mean ± SEM) at 15-, 30-, 45-, 
60-, and 75-minutes post administration in the oxytocin (solid line) and placebo (dotted line) 
conditions.
3.6 Blood glucose, blood pressure and heart rate
A 2 (drug: OT and placebo) x 2 (Sample: first and second) repeated-measures ANOVA was used to 
analyse blood glucose samples. There was no main effect of drug on blood glucose levels F(1,37) =  
0.28, p = .60. There was, however, a main effect of sample time [F(1,37) =  83.95, p < .001, partial η2 
= .69] with samples taken after eating being significantly higher than before eating.  There was no 
interaction between blood sample time and drug condition F(1,37) =  0.00, p = .98.
A repeated-measures ANOVA assessed the effect of OT and the stress task on blood pressure.  
Baseline blood pressure readings taken 10 minutes before administration of drug and stress tests were 

































































M SD M SD
OT Before Stress 0.50 7.74 -0.66 5.43
After Stress -1.03 7.32 -1.26 5.72
Placebo Before Stress 1.21 6.61 -1.89 7.27
After Stress -0.11 6.25 -1.95 6.67
Table 3: Mean (SD) Baseline-Adjusted Measurements in Systolic and Diastolic Blood Pressure after 
oxytocin (OT) or Placebo (mmHg; n = 38)
There were no main effects of OT on either systolic [F(1,37) = 0.31, p = .58] or diastolic [F(1,37) = 
0.58, p = .45] blood pressure. Neither systolic [F(1,37) = 3.36, p = .08] nor diastolic blood pressure 
[F(1,37) = 0.23, p = .63] changed between pre- and post-stress phases during the sessions. 
Due to equipment error, the heart-rate data from 16 participants was not analysable. The heart-rate 
data for the remaining 23 participants was analysed by a 2 (drug: oxytocin and placebo) x 2 (sample: 
first and second) repeated-measures ANOVA to assess the effect of oxytocin on heart rate.  Baseline 
heart-rate data measured in beats per minute (BPM) was recorded for 10 minutes, then trimmed by the 
first and last two minutes to create a reliable baseline rate. Mean (± SD) heart-rate readings in the 
baseline placebo condition [82.79 ± 19.12 bpm] were below mean (± SD) readings obtained during 
the sing-a-song stress test [95.60 ± 15.57 bpm]. The same pattern was observed in the oxytocin 
sessions, where mean (± SD) heart-rate readings at baseline [82.38 ± 8.98 bpm] were below mean (± 
SD) readings obtained during the sing-a-song stress test [99.91 ± 17.33 bpm].  ANOVA showed no 





























































test period with a large effect: F(1,22) = 29.13, p < .001, partial η2 = .57; no interactions emerged.
To ensure that increases in heart rate during the Sing-a-Song stress test were not due to the 
physiological effects of singing, the anticipatory phase was calculated from 5 to 20 seconds after the 
researcher’s instructions and separated from the test phase, which was calculated from the end of the 
recording backwards for 20 seconds. Results were examined via a t test and the mean increase in heart 
rate during the anticipatory phase (M = 15.64, SD = 3.26) was slightly higher than the mean heart rate 
increase during the singing stress test (M = 15.75, SD = 3.28), but there were no statistically 
significant differences, t(22) = 1.62, p = .12. These results indicate that the rise in heart rate during the 
Sing-a-Song stress test was not driven solely by the physiological impact of singing.
4. DISCUSSION
This study demonstrated for the first time that intranasal administration of 24 IU of OT to women 
significantly reduced postprandial intake of sweet snack foods after stressful tasks, regardless of their 
status as stress eaters or non-stress eaters. Unlike previous studies in men (Ott et al., 2013), OT had no 
significant effect on cortisol levels, suggesting that OT’s attenuation of palatable snacking in the 
absence of hunger is not driven by OT’s suppressive effect on the HPA axis. This is the first study to 
show that OT reduces eating in women, and unlike the previous study by Burmester, Higgs and Terry 
(2018) in males, no reductions were seen on salty snack intake. Self-reported levels of happiness, 
excitement, and alertness declined significantly in the placebo condition but remained stable in the OT 
condition, indicating that OT positively affected mood and arousal by preventing a decline over the 
course of the session. In contrast to previous studies (Ott et al., 2013; e.g. Petersson, 2002b; Uvnas-
Moberg, 1997), OT did not affect blood glucose or blood pressure; it is likely that procedural 
differences account for this. Heart rate was significantly elevated after the stress tests but not affected 
by OT ; it might be that a more nuanced analysis of cardiac response - such as heart rate variability -  
might reveal differences (Petersson, 2002a), but since the primary purpose of the heart rate recording 





























































The magnitude of OT’s inhibition of chocolate cookie snack intake in this female-only sample is 
comparable to that reported in our earlier study that tested men (Burmester et al., 2018): consumption 
dropped by 43% in females and 37% in males. On the other hand, the German research groups of Ott 
and Thienel saw reductions of only 25% in normal weight men and 19.5% in obese men, following a 
similar bogus taste test (Ott et al., 2013; Thienel et al., 2016). The Ott group tested participants on a 
wide array of eating-related measures, but the only significant effect of OT on intake was with 
chocolate cookies, in line with this study as well as our earlier one (Burmester et al., 2018). 
Participants in the German studies fasted for 14.5 hours, then ate breakfast from a buffet, before being 
tested on snack eating 100 minutes after that. It is possible, therefore, that gastric emptying might 
have played a role in triggering snack eating for the German studies’ participants, especially given 
that many of the high-calorie items from the buffet were liquids (e.g. strawberry milk, vanilla 
pudding, juices, honey, etc.).  The neural mechanisms underlying OT’s anorectic capacity are 
complex but involve motivational and physiological changes (for a review, see Sabatier et al., 2014). 
It might be the case that the difference in the magnitude of OT’s effect across experiments reflects its 
differential modulation of palatable food intake in the presence of deprivation-induced hunger versus 
palatable food intake that is not initiated by such mechanisms. 
Although female oestradiol levels vary across the menstrual cycle, in this experiment we did not 
control for menstrual phase or hormone-based contraceptive usage specifically.  However, the 
possibility of hormone suppression by contraceptives was minimised because participants taking 
prescribed medicines were excluded and all participants provided the date of their last menstrual 
cycle.  Menstrual phase was not controlled for at testing, so differences in oestrogen levels may have 
added variance to oxytocin activity, potentially reducing effect sizes in our results.  Nevertheless, 
reductions in palatable snack intake have been observed across different menstrual phases, suggesting 
that oestrogen-related interactions did not drive attenuation of palatable snack intake (Asarian & 
Geary, 2006; Buffenstein, Poppitt, McDevitt, & Prentice, 1995). Further, oestradiol increases OT 
levels but menstrual peaks of oestradiol result in increased appetite and food intake, rather than the 





























































different effect from endogenous rises of OT, which may explain how the data here are unaffected by 
menstrual fluctuations, but further research is required. Aulinas et al. (2018) distinguish between the 
patterns of postprandial peripheral OT release, which remain stable across menstrual phases, and 
fasting levels of peripheral OT recorded before food intake, which vary, to explain the discrepancy. 
However, previous studies rely on peripheral and central OT measurements, which are not tightly 
correlated, so further research is needed to elucidate the effects of oestrogen on central levels of OT 
(Mccullough, Churchland, & Mendez, 2013). 
Stress can preferentially increase consumption of sweet, fatty food (O'Connor, Jones, Conner, 
McMillan, & Ferguson, 2008; Oliver et al., 2000), which may account for salty food intake not 
changing after OT in this experiment unlike for our previous male experiment (Burmester, Higgs, and 
Terry, 2018). In mice, OT reduces consumption of sweet-tasting food including saccharin (Billings et 
al., 2006), whereas OT KO mice overconsume sweet solutions (Amico et al., 2005; Sclafani et al., 
2007).  Animal research has suggested that oxytocin’s anorectic effects are mediated by VTA changes 
that dampen reward (Mullis, Kay, & Williams, 2013).  Here, reductions in sweet-snack eating after 
oxytocin coincided with reductions in sweet-taste sensitivity, suggesting that oxytocin’s alteration of 
sweet sensitivity may also contribute to the attenuation of intake. Although the reduction in sweetness 
rating was only apparent in stress eaters, that group could be expected to be expressing more appetite 
for the chocolate cookies after stress compared to non-stress eaters (van Strien, Gibson, Baňos, 
Cebolla & Winkens, 2019), and indeed sweetness ratings were slightly higher on average for stress 
eaters under placebo conditions. Oxytocin’s reduction of sweetness sensitivity is in line with rodent 
studies but not with previous human research indicating that oxytocin does not significantly affect 
taste ratings (Ott et al., 2013; Thienel et al., 2016).  The different hunger status of participants in this 
study and the Ott and Thienel studies may account for this variability. The addition of acute stress 
promotes sweet food preference as sweet food reduces HPA axis activity (Pecoraro, Reyes, Gomez, 
Bhargava, & Dallman, 2004), so it is possible that oxytocin’s reduction of sweet-taste perception is 
specific to a stress paradigm. 





























































Ott et al. (2013) and Thienel et al. (2016) saw cortisol levels rise after placebo and oxytocin 
administration following a free-choice breakfast buffet, although they were significantly lower in the 
OT condition at 45 minute and two hours post-administration. It is likely that the relatively high 
protein intake (36 g) from their breakfast buffet induced a metabolic processing rise in cortisol 
(Gibson et al., 1999), which was avoided in our study by restricting the protein content of the lunch; 
this could also be related to the reduced postprandial glucose rise after OT treatment (Ott et al., 2013). 
There may be alternative mechanisms through which OT acts to reduce stress eating, such as the 
reward system or the suppression of amygdala activity (Bale, Davis, Auger, Dorsa, & McCarthy, 
2001; Huber, Veinante, & Stoop, 2005).
Nevertheless, Ott et al. (2013) reported that the OT-induced suppression in cortisol (AUC) correlated 
with the reduction in chocolate cookie intake, suggesting a mechanistic link. However, oxytocin’s 
regulation of the HPA axis is context-dependent in rats, where oxytocin attenuates tonic HPA activity 
but not stress-induced (phasic) HPA activity. The serial sevens subtraction stressor employed here is 
widely used to trigger a stress-related cortisol response (Gotlib, Joormann, Minor, & Hallmayer, 
2008), so oxytocin’s effects may have a similar tonic-only effect in humans. The measurement of 
cortisol may also explain the differences between these findings and previous studies. The Gotlib, Ott 
and Thienel groups examined total plasma cortisol, only a small percentage of which is active and that 
is known to be affected by dietary protein intake (Anderson, Rosner, Khan, New, Pang, Wissel, & 
Kappas, 1987) (Gibson et al., 1999), whereas in this study the more active form of salivary cortisol 
was collected.  Another possibility is that males and females react differently to exogenous oxytocin.
As a natural reward, food intake - particularly of sugar - activates many of the same brain areas that 
are engaged by drugs of abuse (Berridge, 1996).  OT has extensive effects on substance use, typically 
reducing intake and suppressing withdrawal effects and cravings for a range of substances that 
activate central reward circuits (such as the mesolimbic dopaminergic system; Bailey, 2014; 
McGregor & Bowen, 2012; Zanos et al., 2014; Zanos et al., 2018). The reduction in non-hunger 
initiated palatable food intake induced by OT might, therefore, be mediated to some degree by a 





























































Hernandez & Hoebel, 1988; Long, Blundell, & Finlayson, 2015; Volkow et al., 2010), which would 
also be compatible with a reduction in sweetness ratings specifically by participants who are prone to 
affect-driven stress eating.  
To conclude, for the first time, we have shown that oxytocin reduces postprandial snacking of 
palatable sweet cookies in females without concomitant reductions in salivary cortisol. The study did 
not measure oestrogen levels or control for menstrual fluctuations, and this would be a useful future 
research direction. The findings suggest that the inhibitory effects of OT on stress-induced palatable 
food intake may not be mediated by the HPA axis, and that OT may reduce palatable food reward in 
women.  OT may, therefore, potentially contribute towards tackling “comfort eating” and the 
concomitant obesity that can arise as a consequence, and these findings provide further support for 
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Highlights for Burmester et al.
 Oxytocin reduced post-stress intake of a sweet fatty snack in healthy women
 In self-reported stress eaters, oxytocin reduced perceived sweetness of the snack
 Oxytocin did not significantly alter salivary cortisol after stress
 Oxytocin treatment may be useful for reducing emotionally driven overeating
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Intranasal oxytocin produces anorectic effects on snack intake in men when tested in the absence of 
deprivation-induced hunger, but its effects on food intake in women without eating disorders have not 
been reported. Oxytocin may reduce food intake by reducing stress eating, since it inhibits ACTH 
release. The present study adopted a double-blind, repeated measures and fully concealed crossover 
protocol in which 38 women self-administered 24 IU of oxytocin or placebo intranasally, ate lunch, 
and underwent two consecutive stress tests. Snack intake was assessed 15-20 minutes after lunch, via 
a sham taste test. Salivary cortisol was measured throughout the test period every 15 minutes. 
Oxytocin significantly reduced sweet fatty snack intake independently of any effect on salivary 
cortisol, which declined over time at a similar rate after either drug or placebo. Ratings of sweet taste 
were slightly reduced by oxytocin, but only in self-reported stress eaters. These results differ from 
previous studies with men that found an effect of oxytocin on postprandial cortisol levels. However, 
previous research assayed the less active form of plasma cortisol and did not control for protein 
intake, which can drive elevated cortisol. The finding that oxytocin reduces snack intake in females 
after acute stress has important implications for appetite regulation and its treatment in obese people 





























































Oxytocin (OT) is a hypothalamic neuropeptide hormone, released into the circulation via the posterior 
pituitary gland that also has central actions known to affect social behaviours (Jones, Barrera, 
Brothers, Ring, & Wahlestedt, 2017). In experimental animals and humans, OT inhibits palatable food 
intake and alters macronutrient metabolism (Leng & Sabatier, 2017; Leslie, Silva, Paloyelis, Blevins, 
& Treasure, 2018). OT also regulates the hypothalamo–pituitary–adrenal axis (HPA) and is released 
both centrally and peripherally in response to both psychological (Carter & Altemus, 1997; Onaka, 
Takayanagi, & Yoshida, 2012) and physical stress (Cardoso, Ellenbogen, Orlando, Bacon, & Joober, 
2013). However, relatively little is known about the role of OT in mediating either the hypophagic or 
hyperphagic effects of stress in human beings; thus, the present study aimed to examine the impact of 
intranasal OT on snack intake with an emphasis on sweet snack intake in women after a stressful task.    
In rats, a dose-dependent reduction in sucrose intake following OT administration has been shown to 
be dependent on activation of oxytocin receptors (OTR) in the ventral tegmental area (VTA Mullis, 
Kay, & Williams, 2013). Activity of the VTA is known to influence palatable food consumption, 
reward, and various motivated behaviours (Lutter and Nestler, 2009) and it has been suggested that 
oxytocin may, therefore, alter the motivation to eat in the absence of hunger. OT knockout (KO) mice 
overconsume sweet-tasting sucrose and noncaloric saccharin but not lipid emulsions (Amico, 
Vollmer, Cai, Miedlar, & Rinaman, 2005). The increased consumption of sucrose solution in OT KO 
mice is not altered by daily shaker platform stress (Billings, Spero, Vollmer, & Amico, 2006), 
suggesting that sucrose hyperphagia in OT KO mice is independent of stress and activation of the 
HPA axis. Furthermore, Sclafani et al. (2007) demonstrated, using isotonic carbohydrate solutions 
that varied in sweetness, that hyperphagia in OT KO mice could be extended to carbohydrate intake in 
general, but did not occur for a palatable, fat-rich emulsion (Intralipid): therefore OT brain pathways 
may contribute to carbohydrate-specific satiation, at least in rodents.
In humans, administration of 24 IU of intranasal oxytocin markedly decreased palatable snack intake 




























































4Higgs, and Terry, 2018). The reductions in total snack intake were primarily driven by a 37% decline 
in sweet snack consumption, specifically chocolate cookie consumption, but a significant attenuation 
of salty cracker intake was also seen. In the same experiment, the intake of bland-tasting oatcakes was 
not affected by OT. A similar effect on sweet snack intake was found by Ott et al. (2013): twenty 
young male participants ate a buffet breakfast, then 1 hour 40 minutes later an OT-induced reduction 
of chocolate cookie intake (by 25%) was found. These studies suggest that OT has anorectic 
properties and may form part of the homeostatic regulatory system of the hypothalamus, interacting 
with hormonal signals such as leptin and cholecystokinin (CCK) to inhibit food intake (Sabatier, 
Leng, & Menzies, 2014). However, factors other than sufficient calorie intake appear to stimulate 
neuronal OT release coinciding with termination of feeding. These include meal onset (Sabatier et al., 
2014), changes in blood osmolality as a result of increased salt intake (Stricker & Verbalis, 1986), 
stomach distension (Calatayud, Quintana, Esplugues, & Barrachina, 1999) and toxin ingestion 
(Olszewski, Waas, Brooks, Herisson, & Levine, 2013). Together, this evidence suggests that OT may 
regulate palatable carbohydrate intake in a non-homeostatic manner, i.e. not dependent on normal 
satiation processes.
OT also interacts with other hormonal systems. The sex steroids, in particular the oestrogens, are 
important regulators of the OT system, resulting in a sex disparity in OT synthesis and receptor 
expression. Oestrogen receptors are expressed in hypothalamic OT neurons, and activation of these 
receptors enhances the anxiolytic effects of OT, suggesting a regulatory role for oestrogen in OT 
release. In addition, oestrogens influence the transcription of both OT and its receptors (McCarthy, 
McDonald, Brooks, & Goldman, 1996; Olszewski et al., 2013; Young, Wang, Donaldson, & Rissman, 
1998). To a lesser extent, testosterone influences OT receptor expression, and its effects vary 
according to brain region (Insel, Young, Witt, & Crews, 1993). Relatedly, sex hormones exert sex-
dependent stress effects that can lead to higher stress levels in women than men. Premenopausal 
women, for example, are vulnerable to monthly variations in oestrogen and progesterone that regulate 
central levels of serotonin and the progesterone metabolite, allopregnanolone, two endogenous 




























































5between OT and oestrogen systems which may at least partially explain the sex-dependent effects of 
OT on certain behaviours (Carter, 2007; Choleris et al., 2003; Rilling et al., 2014).
Intracerebral OT given to rats that were exposed to emotional and physical stressors inhibited basal 
HPA axis activity but potentiated adrenocorticotropic hormone (ACTH) release under stress 
conditions, indicating a differential involvement of central OT on HPA axis functioning (Neumann, 
Krömer, Toschi, & Ebner, 2000). This effect was reversible by OT receptor antagonism (Neumann, 
Torner, & Wigger, 1999; Neumann, Wigger, Torner, Holsboer, & Landgraf, 2000) clearly indicating 
an OT receptor-mediated effect. In a further experiment, both the tonic reductions in HPA axis 
activity induced by brain OT as well as on the stress-induced release of ACTH by intracerebral OT 
were shown to be sex independent (2000). In rat dams and women, lactation-related rises in OT 
reliably reduce ACTH and corticosterone/cortisol (Amico, Johnston, & Vagnucci, 1994; Chiodera et 
al., 1991). Oxytocin and cortisol levels are bi-directionally interactive (Tops, Van Peer, Korf, Wijers, 
& Tucker, 2007) and cortisol levels appear so tightly linked to oxytocin that cortisol measurement has 
been used as an experimental proxy for oxytocin (Meinlschmidt & Heim, 2007). In previous studies 
showing OT’s attenuation of palatable food intake, a concomitant decrease in cortisol was found after 
OT administration but not after placebo, perhaps indicating that a cortisol-mediated effect underlies 
OT’s influence on  palatable snack intake (Ott et al., 2013; Thienel et al., 2016).
In women with high cortisol reactivity to an acute stressor, greater stress-induced eating is observed 
(Epel, Lapidus, McEwen, & Brownell, 2001), and although about equal numbers of the population 
overeat and undereat, as do neither (Wardle & Gibson, 2016), there is a gender disparity, with women 
typically engaging in stress eating more frequently than men (Gibson, 2012). Eating energy-dense 
foods can relieve the negative consequences of stress and suppress the HPA axis (Buwalda, Blom, 
Koolhaas, & van Dijk, 2001; Dallman et al., 2003; Foster et al., 2008; Pecoraro, Reyes, Gomez, 
Bhargava, & Dallman, 2004). Eating in response to stress typically involves choosing highly palatable 
and energy-dense foods (Oliver, Wardle, & Gibson, 2000; Pliner & Mann, 2004) but the severity of 
the stressor may influence these patterns (Charmandari, Tsigos, & Chrousos, 2005). Acute stressors 




























































6leave eating unchanged (Wardle & Gibson, 2016). Chronic stress may have the opposite effect: for 
instance, chronically-stressed women who comfort eat have been shown to have a blunted cortisol 
response to an acute stressor (Tomiyama, Dallman, & Epel, 2011). A suppressed cortisol response 
may also arise from the accumulation of visceral fat (Tomiyama et al., 2011), but using acute stressors 
such as public speaking and mathematical tasks, laboratory studies have produced robust stress-eating 
responses irrespective of BMI (Epel et al., 2001).  
Given the prevalence of stress eating in women and the central elevation of OT by oestradiol, we 
would expect a sex difference with respect to the impact of OT administration on stress eating, with 
the inhibition of snack eating by OT likely to be enhanced in females. Here we investigate, for the 
first time, the effect of OT on stress-related snack intake that is not initiated by deprivation-induced 
hunger in women.  To minimise the possibility that the effects of OT may be attributed to the 
modulation of such hunger-driven eating, participants were provided with lunch 20 minutes before a 
post-stress covert snack-eating test.  Salivary cortisol was measured at frequent intervals for the first 
time in this OT and stress-eating experimental paradigm; furthermore, to avoid cortisol increases 
provoked by protein consumption (Gibson et al., 1999), the protein content of the preloaded food was 
kept below 10 g.  
2. MATERIALS AND METHODS
2.1 Design
 A double-blind, placebo-controlled, randomised, and counterbalanced crossover protocol was 
implemented using a within-subjects design comprising drug or placebo tests scheduled about a week 
apart. The aims of the experiment were disguised to minimise undesirable impression management 
and participants were informed that the study investigated the effect of OT on stress and sensory 






























































7Thirty-eight healthy women aged between 19 and 51 years, M (SD) = 26.6 (8.6) years were recruited 
both by word-of-mouth and in exchange for university course credits. Their body mass indices ranged 
from 18.4 to 35.0 kg/m2, M (SD) = 24.8 (4.2) kg/m2, indicating a range from low to obese. Although 
participants were not selected on the basis of their stress eating, we used a bespoke questionnaire that 
asked about a range of stress responses that included effects on eating, in order to disguise the 
experimental aims. The questionnaire asked participants to indicate how they react to a number of 
stress scenarios by rating their top three responses from the following options: “sleep”, “disturbed 
sleep”, “exercise”, “chat with someone”, “work/study”, “eat”, “reduced eating”, “smoke/vape”, 
“read/watch TV or film”, “cry”, “drink alcohol”, “let your hair down”, “drugs of abuse”, and “none of 
the options”.  Although all of the women demonstrated they were premenopausal by providing the 
date of their most recent menstrual cycle, at least three women (aged 46, 48 and 51 years) may have 
been perimenopausal due to their age.  Participants with self-declared food allergies, diabetes, 
pregnant, breastfeeding, on prescription medicines or a vegan diet, were excluded. Altered 
endogenous OT function is associated with high emotional arousal or stress (e.g. bereavement, 
financial windfall) so participants reporting such events were also excluded (Engelmann, Ebner, 
Landgraf, Holsboer, & Wotjak, 1999; Kovacs, 1986). Due to possible changes in taste sensitivity and 
suppressed eating (Audrain-McGovern & Benowitz, 2011; Gromysz-Kalkowska, Wojcik, 
Szubartowska, & Unkiewicz-Winiarczyk, 2002), regular smokers were also excluded. Participants 
were asked not to consume alcohol or non-steroidal anti-inflammatory drugs for 24 hours beforehand 
and to abstain from consuming food and sugary drinks for two hours before the experiment.
2.3 Materials
OT and vehicle were supplied by Victoria Pharmacy, Switzerland. Salter’s electronic food scales were 
used to weigh food and Koogeek’s biometric impedance scales were used to weigh participants and 
estimate fat ratio. Blood glucose levels were obtained using Accu-Chek’s ‘Aviv’ hand-held monitor, 
the Omron handheld M2 model measured blood pressure, and Biopac’s SC-Flex Pro was used with a 
fingertip sensor to measure heart rate. Saliva was collected in ‘Salivettes’ (Sarstedt UK, Leicester, 





























































Sham sensory tasks used the following: Elite Healthcare’s ‘Two Point Discriminator Touch-Test’; 
synthetic almond- and soap-scented smelling bottles (Bilendy Ltd, UK); and a stopwatch. Bespoke 
materials for the sham visual tasks were A4-sized laminated colour prints of famous paintings and 
A6-sized laminated black-and-white pictures of castles for the “spot-the-difference” test. Music and 
Neuroimaging Laboratory’s pitch discrimination test was taken online (Schlaug, 2017). 
Self-report measures: Romantic involvement was estimated using Rubin’s (1970) Romantic Love 
Scale. Self-monitoring behaviour was assessed using Synder’s scale (1974) and anxiety was estimated 
with the trait scale of the State-Trait Anxiety inventory (STAI; Spielberger, Gorsuch, & Lushene, 
1970). The Dutch Eating Behaviour Questionnaire (DEBQ Van Strien, Frijters, Bergers, & Defares, 
1986) assesses levels of restrained (10 items), emotional (13 items), and external (10 items; one 
reversed) eating, with each scale having a range of mean scores from 1 to 5; a higher score reflects 
higher levels of the eating dimension.
Mood and appetite parameters were measured using a bespoke visual analogue scale (VAS) 
examining levels of happiness, excitement, fullness, thirst, anxiousness, and alertness with 100 mm 
lines anchored at “not at all” and “as much as I can imagine”. For the taste test, VAS lines fixed by 
“not at all” and “as much as I can imagine” were presented to measure oatcake palatability, cracker 
saltiness, and chocolate cookie sweetness.  
For the low-protein lunch, each participant was provided with a pre-packaged supermarket lunch 
(Waitrose ‘Pesto and Spinach Salad’, 376 kcal, 190 g).  In the snack test, the three foods were 
chocolate cookies (Waitrose ‘Triple Chunk Chocolate Chip’, 127 kcal, 25 g per unit, 450 g per bowl), 
TUC Classic Crackers (17 kcal, 5.4 g per unit, 230 g per bowl), and Sainsbury’s Oatcakes (47 kcal, 
10.4 g per unit, 300 g per bowl). As per previous experiments, each snack-food type was matched for 
calorie content and macronutrients (see Burmester, Higgs, & Terry, 2018, for full details) and 
presented in a separate bowl filled to the top, in order that substantial amounts could be eaten without 





























































The timeline of events in a test session is shown in Table 1. After providing informed consent and 
confirming compliance with the inclusion and exclusion criteria, participants provided the first of two 
baseline saliva samples by drooling into the collection tube; at least 1 ml was collected with each 
sample. Participants next completed the first of three mood VAS scales. Baseline blood pressure was 
taken as a biomarker of stress, and baseline blood glucose was then measured as OT affects 
postprandial glucose metabolism. Participant height, age, time since last meal, and content of last 
meal were recorded, and the second baseline cortisol sample was collected.  
Next, the participant self-administered either 24 IU of OT or placebo, depending on session, under the 
supervision of the researcher, with six puffs alternated by nostril every 30 seconds; both the 
participant and the researcher were blind to the drug condition. Before participants were asked to eat 
the lunch provided, a measure of romantic love status (Rubin, 1970) was obtained in each session, 
because romantic attachment can influence OT’s effects. Because thirst can sometimes be experienced 
as hunger (Balleine, 1994), participants were offered water and a maximum of 100 ml was provided 
with their lunch; participants were also required to rinse out their mouths with a small sip of water 
after food to reduce salivary sample contamination. 
To support the purpose of the study as it had been described to the participants, two sham sensory 
tasks were presented: a two-point discrimination touch test was conducted on the right index finger to 
identify the smallest interval, in millimetres, that could be sensed, and an olfactory test with smelling 
bottles containing synthetic soap or almond scents, depending on session, was then presented. Saliva 
was again drooled into the Salivettes and the participant’s left hand was rested on the table top and a 
heart rate sensor placed on the middle finger. While keeping the hand still a 10-minute baseline 
recording was made while the participant watched a neutral film, at the end of which they were 
allowed to move their arm briefly and re-position it, if uncomfortable.  
Stress was then induced by the participant being instructed to sing a song for a minute; heart rate 





























































selection or style, and the researchers stopped all activity to create tension and watched the participant 
whose 60 seconds of singing was timed by stop-watch. At the end of the singing, the heart rate 
recording was paused, and the participant was instructed on the serial sevens task (Smith, 1967). 
Heart rate recording was resumed and a random starting number between 700 and 800 was given and 
the participant began 60 seconds of subtracting seven from the running total. Immediately following 
the second stress test, a saliva sample was taken, and blood pressure was measured.  
Next, a taste test was conducted with the three snack foods. Small pieces of each snack, weighing 
about a gram, were provided for the participant to taste and rate on a VAS. Another mood/hunger 
VAS was then completed, and the sham pitch test was completed online. After the pitch test, another 
saliva sample was taken, followed by the first sham visual task, which involved presenting one of two 
near-identical spot-the-difference pictures for 30 seconds. Then the critical snack test occurred: at 45-
minutes post drug/placebo administration, the participant was instructed to enjoy a 10 minute 
‘cognitive break’, let her mind ‘relax’, and select a preferred picture from a choice of five A4-sized 
prints of famous paintings. The experimenters announced that they would leave the room during the 
participant’s ‘cognitive break’, and it was mentioned that the snack food would be thrown away after 
the experiment due to health and safety regulations, therefore they were free to help themselves to as 
much of the snack food as they wished. The snack test period lasted 10 mins, after which the second 
spot-the-difference picture was presented for 30 seconds, and the participant was asked to identify the 
difference between the two pictures.  
After the break, the participant provided another saliva sample and completed a mood/hunger VAS.  
Next, the STAI was completed as a subjective measure of participant stress, then blood pressure and 
blood glucose were measured. One last saliva sample was provided. Finally, before participants left, 
they were asked whether they thought they had been given OT or placebo. At the end of the second 
visit, participant body mass was measured. Lunch and snack test foods were weighed before and after 
testing. Each session lasted about 95 mins; after the completion of the experiment, participants were 






























































Table 1: Timeline of Experimental Session
Saliva assays for cortisol: Samples were centrifuged at 1000 × g for 2 min, and supernatant was stored 
at −20C for 1 to 6 days and then -80C until assay.  Saliva cortisol levels were measured all in the 
same day in duplicate by Surrey Assays Ltd by radioimmunoassay adapted from Riad-Fahmy et al. 
(1979). Limit of detection was 0.44 +/- 0.15 nmol/L and quality controls were low = 3.2 +/- 0.4 
nmol/L CV = 11.6%; medium = 17.7 +/- 1.7 nmol/L CV = 9.6%, and high = 48.2 +/- 3.2 nmol/L CV 
= 6.7%.
2.5 Data analysis
Data were analysed using Statistical Package for the Social Sciences software (SPSS) version 25.  
Stress eating status was determined from the bespoke questionnaire by a participant indicating that 
eating was a stress response to one or more of the six situations presented. To grade the stress eating, 
a count of the number of situations that triggered stress eating was made for participants who reported 
stress eating to give a score from 1 to 6.  Differences in chocolate cookie consumption, salty cracker 
consumption, oatcake consumption and snack food sensory taste tests for self-rated stress eaters and 





































































































































































































































































conditions.  Taste sensitivity measures were also analysed using a repeated-measures analysis of 
variance (RMANOVA) for OT and placebo conditions.  Baseline-adjusted scores were calculated for 
self-reported mood and appetite VAS by subtracting scores from the first VAS before administration 
of OT or placebo from scores on the second VAS and scores on the third VAS and analysed via t tests 
and a 2 (Drug: OT or placebo) x 2 (Time: post stress or post stress + 30’) RMANOVA was conducted 
for each of the VAS items using baseline-adjusted change scores.  The means of the two baseline 
cortisol samples (sample 1 and sample 2) were subtracted from each of the remaining samples within 
the same session (samples 3 to samples 7) to create baseline-adjusted data.    Both area under the 
curve with respect to increase (AUCi)  and a RMANOVA were used to compare baseline-adjusted 
cortisol scores for salivary cortisol levels of samples 3 to 7 taken at 15-, 30-, 45-, 60-, and 75-minutes 
post administration between drug conditions (Figure 4).
3. RESULTS
3.1 Participant Characteristics
For the dietary restraint component of the DEBQ, participants scored higher than the mean of 
normative scores [M (SD) = 2.75(0.79)] from the British validation of the DEBQ using healthy 
women (Wardle, 1987); M (SD) = 3.19 (1.1). Participants scored slightly above a normative mean [M 
(SD) = 3.19 (1.1)] on the DEBQ external eating scale, M (SD) = 3.33 (0.59), but at the low end of 
normative data [M (SD) = 2.65 (0.72)] for emotional eating, M (SD) = 1.93 (0.76).  Scores on the self-
monitoring scale were below average, M (SD) = 8.89 (2.65) and scores on the STAI (range from 0-80) 
were above normative averages [trait: M = 34.79, SD = 9.22 and state: M = 37.89, SD = 9.90] for both 
trait, M (SD) = 45.50 (4.61) and state, M (SD) = 44.91 (3.04) components. Scores on the romantic 
love scale were low-average M (SD) = 76.65 (14.86) and were no different between placebo and 
oxytocin conditions: t(37) = 0.14, p = .89.
Self-Rated Stress Eating Status: The DEBQ emotional eating scores for self-reported stress eaters (M 





























































F(1,26) = 0.006, p = .94]. 
3.2 Snack food intake
There was no main effect of stress eating status on consumption of snack foods: F(1,36) = 0.14, p = 
.71. There was, however, a main effect of OT [F(1,36) = 12.38, p < .001, partial η2 = .26; see Figure 
1], whereby significantly less snack food in total was eaten in the OT condition, p = .001, and this was 
not qualified by an interaction with stress eating status: F(1,36) = 2.57, p = .12. The assumption of 
sphericity was violated for snack type [χ2(2) = 28.14, p < .001] and the interaction between snack type 
and drug [χ2(2) = 19.22, p < .001], so Greenhouse-Geisser adjustments were used: ε = 0.64 for snack 
type, ε = 0.71 for interaction. A main effect of snack type was found: F(1.29,46.38) = 24.75, p < .001, 
partial η2 = .41. Post-hoc Bonferroni comparisons showed that significantly more of sweet (chocolate 
cookies) than salty (crackers) snacks were consumed (p < .001), and significantly more of sweet than 
bland (oatcakes) snacks were eaten (p < .001). There was no significant difference between salty and 
bland snack consumption (p = .28); thus, overall participants ate more chocolate cookies than other 
snack types. There was no interaction between snack type and participants’ self-rated stress eating 
status: F(1.29,46.38) = 0.60, p = .48. There was, however, a significant interaction between drug 
condition and snack type [F(1.41,50.61) = 19.71, p = < .001], such that participants ate considerably 
less chocolate snack in the OT condition (Figure 1). The interaction between drug condition and snack 




















































































Figure 1: Effects of 24 IU oxytocin (OT) vs. placebo on the intake (mean g ± SEM; n = 38) of three 
different snacks collapsed across stress eaters (n = 15) and non-stress eaters (n = 23). Choc Bisc = 
chocolate chip cookies.
The drug by snack type interaction was further examined by post-hoc t tests. There were no 
differences in snack consumption between stress eaters and non-stress eaters, so participants were 
analysed as a whole. OT significantly reduced the intake of chocolate cookies [t(37) = 5.10 p < .001] 
but not salty crackers [t(37) = .262 p = .80] or oatcakes [t(37) = 1.18 p = .25]. As expected, there was 
no significant difference between conditions on the consumption of lunch (a study requirement), t(37) 
= .74 p = .47.  
3.3 Snack Food Sensory Taste Tests
OT tended to reduce the reported sweetness of the chocolate cookies for stress eaters but tended to 
increase rated sweetness for non-stress eaters [Figure 2: drug x stress eating interaction, F(1,36) = 





























































(Fs < 1): overall mean sweetness ratings for chocolate cookies were 77.50 mm (SD = 12.76) in the 
placebo condition and 77.76 mm (SD = 13.50) after OT, i.e. did not differ, t(37) = 0.11 p = .91 .  
The mean saltiness ratings for crackers were similar in both the placebo (55.79 mm, SD = 19.52 mm) 
and oxytocin conditions (56.26 mm, SD = 17.41 mm), t(37) = 0.17 p = .87.  However, self-reported 
stress eaters rated crackers as significantly saltier than did non-stress eaters, irrespective of drug 
[Figure 3: stress eater status main effect, F(1,36) = 5.16, p = .029, partial η2 = .13].  The drug effect 
and interaction effect were not significant (Fs  < 1).




































Self-Reported Stress Eating Status
 
Figure 2: Interaction of drug (oxytocin vs placebo) and stress eating status (stress eater [n=15] vs non-





























































































Self-Reported Stress Eating Status
Figure 3: Interaction of drug (oxytocin vs placebo) and stress eating status (stress eater [n=15] vs non-
stress eater [n=23]) on rated saltiness of crackers.
Oatcakes were rated similarly for palatability in the placebo condition (M = 34.92 mm, SD = 22.46 
mm) as in the oxytocin condition (M = 37.63 mm, SD = 26.53 mm) t(37) = 0.62 p = .54, and 
palatability ratings did not differ between stress eating groups (Fs < 1.1).  
3.4 Self-reported mood and appetite VAS
Overall, there were no significant differences between drug conditions for changes in alertness, 
anxiety, happiness, excitement, fullness or thirst.  However, over the course of the placebo session 
there was a significant decline in ratings of happiness [t(37) = 2.17 p =  .037], excitement [t(37) = 
2.85 p = 0.07], and alertness [t(37) = 2.62 p = .013], whereas in the OT session, participant ratings of 





























































VAS item Time point Placebo OT
M SD M SD
Alert Baseline 51.50 23.13 53.39 23.61
Post-stress 49.58 22.45 47.74 24.38
Post-stress+30’ 42.58 23.14 48.87 22.81
Anxious Baseline 20.74 20.38 22.21 22.87
Post-stress 19.34 18.70 17.21 16.97
Post-stress+30’ 18.68 18.94 17.87 15.68
Excited Baseline 36.32 19.76 38.21 22.49
Post-stress 38.71 24.38 37.55 22.08
Post-stress+30’ 31.76 19.77 35.45 23.36
Full Baseline 23.45 19.78 31.92 24.59
Post-stress 60.39 22.59 60.71 20.44
Post-stress+30’ 64.53 22.45 64.84 23.30
Happy Baseline 58.68 18.11 56.29 21.12
Post-stress 62.89 16.06 57.29 19.02
Post-stress+30’ 58.18 18.86 58.24 19.83





























































Post-stress 68.47 20.64 59.29 23.23
Post-stress+30’ 68.18 22.76 66.58 24.88
Table 2: Mean (SD) 100-mm VAS mood and appetite ratings for oxytocin (OT) and placebo 
conditions over baseline and post-stress time points (n = 38)
There was no main effect of drug condition [F(1,37) 0.23, p = .89] or sample time [F(1,37) 1.84, p = 
.12] for the “happiness” item but there was a significant interaction between drug and sample time 
[F(1,37) 5.13, p = .029, partial η2 = .12] such that self-rated happiness declined from a slight rise 
immediately post-stress to the end of the session in the placebo condition but it did not drop in the 
oxytocin condition. There were no further main effects or interactions for the remaining VAS items, 
except that self-rated “excitement” decreased significantly by the last measure in both drug conditions 
[F(1,37) = 9.07, p = .005, partial η2 = .20] and ratings of fullness increased significantly through both 
sessions [F(1,37) = 6.80, p = .013, partial η2 = .15].
3.5 Cortisol
Oxytocin did not significantly change cortisol levels [F(1,37) = .85, p = .36]. Mauchly’s test indicated 
that the assumption of sphericity had been violated for the sample time factor [χ2(9) = 72.00, p < .001] 
and the interaction between sample and drug [χ2(9) = 36.29, p < .001], so degrees of freedom were 
estimated using the Greenhouse-Geisser estimates of sphericity (ε = 0.50 for sample, ε = 0.65 for 
interaction).  As expected, there was a main effect of sample time with salivary cortisol quantities 
dropping over time [F(2.0, 74.1) =  7.76, p = .001, partial η2 = .10] but there was no interaction with 
drug [F(2.6, 96.0) =  0.82, p = .47].
No significant differences between drug conditions were seen in a repeated-measures ANOVA using 
the AUCi of baseline-adjusted cortisol, F(1,37) 0.74, p = .40.  Paired t tests on peak cortisol were not 
significantly different between conditions using baseline-adjusted data, t(37) = .74, p = .47, and t tests 





























































Finally, there was no significant correlation between AUCi measures and chocolate cookie snack 























Figure 4: Baseline-adjusted salivary cortisol concentration (nmol/L; mean ± SEM) at 15-, 30-, 45-, 
60-, and 75-minutes post administration in the oxytocin (solid line) and placebo (dotted line) 
conditions.
3.6 Blood glucose, blood pressure and heart rate
A 2 (drug: OT and placebo) x 2 (Sample: first and second) repeated-measures ANOVA was used to 
analyse blood glucose samples. There was no main effect of drug on blood glucose levels F(1,37) =  
0.28, p = .60. There was, however, a main effect of sample time [F(1,37) =  83.95, p < .001, partial η2 
= .69] with samples taken after eating being significantly higher than before eating.  There was no 
interaction between blood sample time and drug condition F(1,37) =  0.00, p = .98.
A repeated-measures ANOVA assessed the effect of OT and the stress task on blood pressure.  
Baseline blood pressure readings taken 10 minutes before administration of drug and stress tests were 

































































M SD M SD
OT Before Stress 0.50 7.74 -0.66 5.43
After Stress -1.03 7.32 -1.26 5.72
Placebo Before Stress 1.21 6.61 -1.89 7.27
After Stress -0.11 6.25 -1.95 6.67
Table 3: Mean (SD) Baseline-Adjusted Measurements in Systolic and Diastolic Blood Pressure after 
oxytocin (OT) or Placebo (mmHg; n = 38)
There were no main effects of OT on either systolic [F(1,37) = 0.31, p = .58] or diastolic [F(1,37) = 
0.58, p = .45] blood pressure. Neither systolic [F(1,37) = 3.36, p = .08] nor diastolic blood pressure 
[F(1,37) = 0.23, p = .63] changed between pre- and post-stress phases during the sessions. 
Due to equipment error, the heart-rate data from 16 participants was not analysable. The heart-rate 
data for the remaining 23 participants was analysed by a 2 (drug: oxytocin and placebo) x 2 (sample: 
first and second) repeated-measures ANOVA to assess the effect of oxytocin on heart rate.  Baseline 
heart-rate data measured in beats per minute (BPM) was recorded for 10 minutes, then trimmed by the 
first and last two minutes to create a reliable baseline rate. Mean (± SD) heart-rate readings in the 
baseline placebo condition [82.79 ± 19.12 bpm] were below mean (± SD) readings obtained during 
the sing-a-song stress test [95.60 ± 15.57 bpm]. The same pattern was observed in the oxytocin 
sessions, where mean (± SD) heart-rate readings at baseline [82.38 ± 8.98 bpm] were below mean (± 
SD) readings obtained during the sing-a-song stress test [99.91 ± 17.33 bpm].  ANOVA showed no 





























































test period with a large effect: F(1,22) = 29.13, p < .001, partial η2 = .57; no interactions emerged.
To ensure that increases in heart rate during the Sing-a-Song stress test were not due to the 
physiological effects of singing, the anticipatory phase was calculated from 5 to 20 seconds after the 
researcher’s instructions and separated from the test phase, which was calculated from the end of the 
recording backwards for 20 seconds. Results were examined via a t test and the mean increase in heart 
rate during the anticipatory phase (M = 15.64, SD = 3.26) was slightly higher than the mean heart rate 
increase during the singing stress test (M = 15.75, SD = 3.28), but there were no statistically 
significant differences, t(22) = 1.62, p = .12. These results indicate that the rise in heart rate during the 
Sing-a-Song stress test was not driven solely by the physiological impact of singing.
4. DISCUSSION
This study demonstrated for the first time that intranasal administration of 24 IU of OT to women 
significantly reduced postprandial intake of sweet snack foods after stressful tasks, regardless of their 
status as stress eaters or non-stress eaters. Unlike previous studies in men (Ott et al., 2013), OT had no 
significant effect on cortisol levels, suggesting that OT’s attenuation of palatable snacking in the 
absence of hunger is not driven by OT’s suppressive effect on the HPA axis. This is the first study to 
show that OT reduces eating in women, and unlike the previous study by Burmester, Higgs and Terry 
(2018) in males, no reductions were seen on salty snack intake. Self-reported levels of happiness, 
excitement, and alertness declined significantly in the placebo condition but remained stable in the OT 
condition, indicating that OT positively affected mood and arousal by preventing a decline over the 
course of the session. In contrast to previous studies (Ott et al., 2013; e.g. Petersson, 2002b; Uvnas-
Moberg, 1997), OT did not affect blood glucose or blood pressure; it is likely that procedural 
differences account for this. Heart rate was significantly elevated after the stress tests but not affected 
by OT ; it might be that a more nuanced analysis of cardiac response - such as heart rate variability -  
might reveal differences (Petersson, 2002a), but since the primary purpose of the heart rate recording 





























































The magnitude of OT’s inhibition of chocolate cookie snack intake in this female-only sample is 
comparable to that reported in our earlier study that tested men (Burmester et al., 2018): consumption 
dropped by 43% in females and 37% in males. On the other hand, the German research groups of Ott 
and Thienel saw reductions of only 25% in normal weight men and 19.5% in obese men, following a 
similar bogus taste test (Ott et al., 2013; Thienel et al., 2016). The Ott group tested participants on a 
wide array of eating-related measures, but the only significant effect of OT on intake was with 
chocolate cookies, in line with this study as well as our earlier one (Burmester et al., 2018). 
Participants in the German studies fasted for 14.5 hours, then ate breakfast from a buffet, before being 
tested on snack eating 100 minutes after that. It is possible, therefore, that gastric emptying might 
have played a role in triggering snack eating for the German studies’ participants, especially given 
that many of the high-calorie items from the buffet were liquids (e.g. strawberry milk, vanilla 
pudding, juices, honey, etc.).  The neural mechanisms underlying OT’s anorectic capacity are 
complex but involve motivational and physiological changes (for a review, see Sabatier et al., 2014). 
It might be the case that the difference in the magnitude of OT’s effect across experiments reflects its 
differential modulation of palatable food intake in the presence of deprivation-induced hunger versus 
palatable food intake that is not initiated by such mechanisms. 
Although female oestradiol levels vary across the menstrual cycle, in this experiment we did not 
control for menstrual phase or hormone-based contraceptive usage specifically.  However, the 
possibility of hormone suppression by contraceptives was minimised because participants taking 
prescribed medicines were excluded and all participants provided the date of their last menstrual 
cycle.  Menstrual phase was not controlled for at testing, so differences in oestrogen levels may have 
added variance to oxytocin activity, potentially reducing effect sizes in our results.  Nevertheless, 
reductions in palatable snack intake have been observed across different menstrual phases, suggesting 
that oestrogen-related interactions did not drive attenuation of palatable snack intake (Asarian & 
Geary, 2006; Buffenstein, Poppitt, McDevitt, & Prentice, 1995). Further, oestradiol increases OT 
levels but menstrual peaks of oestradiol result in increased appetite and food intake, rather than the 





























































different effect from endogenous rises of OT, which may explain how the data here are unaffected by 
menstrual fluctuations, but further research is required. Aulinas et al. (2018) distinguish between the 
patterns of postprandial peripheral OT release, which remain stable across menstrual phases, and 
fasting levels of peripheral OT recorded before food intake, which vary, to explain the discrepancy. 
However, previous studies rely on peripheral and central OT measurements, which are not tightly 
correlated, so further research is needed to elucidate the effects of oestrogen on central levels of OT 
(Mccullough, Churchland, & Mendez, 2013). 
Stress can preferentially increase consumption of sweet, fatty food (O'Connor, Jones, Conner, 
McMillan, & Ferguson, 2008; Oliver et al., 2000), which may account for salty food intake not 
changing after OT in this experiment unlike for our previous male experiment (Burmester, Higgs, and 
Terry, 2018). In mice, OT reduces consumption of sweet-tasting food including saccharin (Billings et 
al., 2006), whereas OT KO mice overconsume sweet solutions (Amico et al., 2005; Sclafani et al., 
2007).  Animal research has suggested that oxytocin’s anorectic effects are mediated by VTA changes 
that dampen reward (Mullis, Kay, & Williams, 2013).  Here, reductions in sweet-snack eating after 
oxytocin coincided with reductions in sweet-taste sensitivity, suggesting that oxytocin’s alteration of 
sweet sensitivity may also contribute to the attenuation of intake. Although the reduction in sweetness 
rating was only apparent in stress eaters, that group could be expected to be expressing more appetite 
for the chocolate cookies after stress compared to non-stress eaters (van Strien, Gibson, Baňos, 
Cebolla & Winkens, 2019), and indeed sweetness ratings were slightly higher on average for stress 
eaters under placebo conditions. Oxytocin’s reduction of sweetness sensitivity is in line with rodent 
studies but not with previous human research indicating that oxytocin does not significantly affect 
taste ratings (Ott et al., 2013; Thienel et al., 2016).  The different hunger status of participants in this 
study and the Ott and Thienel studies may account for this variability. The addition of acute stress 
promotes sweet food preference as sweet food reduces HPA axis activity (Pecoraro, Reyes, Gomez, 
Bhargava, & Dallman, 2004), so it is possible that oxytocin’s reduction of sweet-taste perception is 
specific to a stress paradigm. 





























































Ott et al. (2013) and Thienel et al. (2016) saw cortisol levels rise after placebo and oxytocin 
administration following a free-choice breakfast buffet, although they were significantly lower in the 
OT condition at 45 minute and two hours post-administration. It is likely that the relatively high 
protein intake (36 g) from their breakfast buffet induced a metabolic processing rise in cortisol 
(Gibson et al., 1999), which was avoided in our study by restricting the protein content of the lunch; 
this could also be related to the reduced postprandial glucose rise after OT treatment (Ott et al., 2013). 
There may be alternative mechanisms through which OT acts to reduce stress eating, such as the 
reward system or the suppression of amygdala activity (Bale, Davis, Auger, Dorsa, & McCarthy, 
2001; Huber, Veinante, & Stoop, 2005).
Nevertheless, Ott et al. (2013) reported that the OT-induced suppression in cortisol (AUC) correlated 
with the reduction in chocolate cookie intake, suggesting a mechanistic link. However, oxytocin’s 
regulation of the HPA axis is context-dependent in rats, where oxytocin attenuates tonic HPA activity 
but not stress-induced (phasic) HPA activity. The serial sevens subtraction stressor employed here is 
widely used to trigger a stress-related cortisol response (Gotlib, Joormann, Minor, & Hallmayer, 
2008), so oxytocin’s effects may have a similar tonic-only effect in humans. The measurement of 
cortisol may also explain the differences between these findings and previous studies. The Gotlib, Ott 
and Thienel groups examined total plasma cortisol, only a small percentage of which is active and that 
is known to be affected by dietary protein intake (Anderson, Rosner, Khan, New, Pang, Wissel, & 
Kappas, 1987) (Gibson et al., 1999), whereas in this study the more active form of salivary cortisol 
was collected.  Another possibility is that males and females react differently to exogenous oxytocin.
As a natural reward, food intake - particularly of sugar - activates many of the same brain areas that 
are engaged by drugs of abuse (Berridge, 1996).  OT has extensive effects on substance use, typically 
reducing intake and suppressing withdrawal effects and cravings for a range of substances that 
activate central reward circuits (such as the mesolimbic dopaminergic system; Bailey, 2014; 
McGregor & Bowen, 2012; Zanos et al., 2014; Zanos et al., 2018). The reduction in non-hunger 
initiated palatable food intake induced by OT might, therefore, be mediated to some degree by a 





























































Hernandez & Hoebel, 1988; Long, Blundell, & Finlayson, 2015; Volkow et al., 2010), which would 
also be compatible with a reduction in sweetness ratings specifically by participants who are prone to 
affect-driven stress eating.  
To conclude, for the first time, we have shown that oxytocin reduces postprandial snacking of 
palatable sweet cookies in females without concomitant reductions in salivary cortisol. The study did 
not measure oestrogen levels or control for menstrual fluctuations, and this would be a useful future 
research direction. The findings suggest that the inhibitory effects of OT on stress-induced palatable 
food intake may not be mediated by the HPA axis, and that OT may reduce palatable food reward in 
women.  OT may, therefore, potentially contribute towards tackling “comfort eating” and the 
concomitant obesity that can arise as a consequence, and these findings provide further support for 
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